Core Facts: What the Study Found
Former smokers who switch to electronic cigarettes after quitting face a higher risk of lung cancer and lung cancer death compared to those who stay completely nicotine-free, according to a landmark study published June 8, 2026, in Nature Medicine.
The study, led by Dr. Yeon Wook Kim of Seoul National University Bundang Hospital, analyzed data from 4,329,288 former smokers in the Korean National Health Insurance Service database. During follow-up through December 2021, 53,534 participants developed lung cancer and 6,351 died from it. The paper was published simultaneously with an interview in Cancerworld Magazine where Kim clarified the study’s implications.
Key Numbers from 4.3 Million Former Smokers
The researchers divided participants by how long they had quit smoking and whether they used e-cigarettes afterward:
- Quit ≥5 years + used e-cigarettes: 2.69 times higher risk of lung cancer death (HR=2.69, 95%CI 1.12–6.46) compared to those who didn’t vape
- Quit <5 years + used e-cigarettes: 23% higher lung cancer risk (HR=1.23) and 71% higher lung cancer death risk (HR=1.71)
- Highest-risk group (ages 50–80 with ≥20 pack-years of smoking history, the group recommended for lung cancer screening): those who quit ≥5 years and vaped had a 4.46 times higher lung cancer death risk
There was no statistically significant difference in lung cancer risk between current smokers who used e-cigarettes and those who didn’t — both groups had similarly elevated risk. This pattern suggests that any inhaled aerosol, whether from cigarettes or e-cigarettes, carries independent pulmonary risk.
Why This Matters for Vapers and Ex-Smokers
The study challenges the central assumption of tobacco harm reduction: that replacing cigarettes with e-cigarettes is a safer choice. While vaping almost certainly exposes users to fewer toxicants than smoking, these results suggest that continued inhalation of any aerosolized substance carries independent lung cancer risk — even years after quitting cigarettes.
E-cigarette aerosol contains carbonyl compounds (formaldehyde, acetaldehyde, acrolein, diacetyl) and toxic metals (chromium, nickel, lead), as detailed in our guide What Is in Vape Juice? The 4 Ingredients Explained. These compounds are known carcinogens, and this study provides the first large-scale human evidence that their concentrations may be high enough to be clinically significant.
The magnitude of the increased risk — HR of 2.69 to 4.46 for the high-risk subgroup — is comparable to or exceeds many established lung cancer risk factors. For context, a 2.69 HR means former long-term smokers who vape are nearly three times more likely to die from lung cancer than those who quit entirely.
Context: Harm Reduction vs. Complete Cessation
The findings arrive at a complex moment for vaping policy. The UK recently reported that vapers now outnumber smokers for the first time, a milestone for harm reduction. Meanwhile, the FDA has loosened enforcement on certain vape products, and countries like France have criminalized nicotine pouches — creating a contradictory regulatory landscape.
Kim told Cancerworld Magazine: “Although probably safer than continuing smoking, vaping may not be completely safe in terms of lung cancer risk when switched from conventional cigarette smoking. Although quitting conventional smoking should be the primary goal, getting free from alternative vaping would be even better.”
This study adds to a growing body of evidence from earlier research including the Carcinogenesis review (March 2026) that found e-cigarettes are “likely to be carcinogenic to humans.” Together, these studies are reshaping the harm reduction debate — shifting the question from “safer than smoking?” to “safe enough to use long-term?” For a comprehensive overview of vaping health concerns, see our Alarming Facts About Vaping guide.
What This Means for Readers
If you quit smoking and switched to vaping, especially with a long smoking history, this study does not suggest going back to cigarettes. Smoking remains far more dangerous. But it does suggest that vaping is not a neutral endpoint.
Three takeaway actions:
- If you’re in the high-risk group (age 50–80, ≥20 pack-years): talk to your doctor about lung cancer screening eligibility. The USPSTF recommends annual low-dose CT scans for this group regardless of vaping status. Earlier detection dramatically improves survival.
- If you quit smoking via vaping: consider a gradual nicotine reduction plan. The healthiest path is complete cessation of all inhaled products. Our guide on nic salt vs. freebase nicotine can help you choose a step-down strategy.
- If you’re considering switching to vaping as a cessation tool: it still works as a short-term aid. But plan for eventual cessation of vaping too — treating e-cigarettes as a permanent replacement carries its own long-term risks.
This study is observational and cannot prove causation. However, the consistency of the dose-response relationship and the biological plausibility (known carcinogens in aerosol) make these findings difficult to dismiss.
继续阅读
- What Is in Vape Juice? The 4 Ingredients Explained (2026)
- How Does Nicotine in E-Cigarettes Affect the Body? What Research Shows
- MTL vs DTL Vaping: What’s the Difference?
- Are Vapes Worse Than Cigarettes? (detailed health comparison between vaping and smoking)
Kevin Li — Founder & Editor, VapeObservation.com Kevin reviews vape products hands-on, prioritizing real-world performance over manufacturer claims. His goal: honest, practical advice that helps everyday vapers make informed choices. Before launching VapeObservation, he was a longtime vaper frustrated by promotional content disguised as reviews. Every article on the site reflects his commitment to data-driven, reader-first testing.
